HISTOLOGICAL REMISSION DOSE NOT OFFER ADDITIONAL BENEFIT FOR ULCERATIVE COLITIS PATIENTS IN ENDOSCOPIC REMISSION

被引:0
|
作者
Alshahrani, Abdulaziz S.
Alsaedi, Mona
Fadida, Ma'ayan
Narula, Neeraj
Marshall, John K.
Rubin, David T.
Christensen, Britt
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo1829
引用
收藏
页码:S940 / S940
页数:1
相关论文
共 50 条
  • [31] A comparison of treatment effects for clinical, endoscopic and histological remission in ulcerative colitis clinical trials
    Sedano, R.
    Hogan, M.
    Zou, G.
    Narula, N.
    Singh, S.
    Ma, C.
    Jairath, V.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I457 - I458
  • [32] A comparison of treatment effects for clinical, endoscopic and histological remission in ulcerative colitis clinical trials
    Sedano, R.
    Hogan, M.
    Zou, G.
    Narula, N.
    Singh, S.
    Ma, C.
    Jairath, V.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I457 - I458
  • [33] Faecal calprotectin in assessing endoscopic and histologic remission in patients with ulcerative colitis
    Mak, W. Y.
    Buisson, A.
    Andersen, M. J., Jr.
    Lei, D.
    Pekow, J.
    Cohen, R. D.
    Kahn, S. A.
    Pereira, B.
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S199 - S200
  • [34] Faecal Calprotectin as a predictor of endoscopic and histologic remission in patients with Ulcerative Colitis
    Hahn, G. Drugg
    Flores, C.
    Afif, W.
    Wild, G.
    Bitton, A.
    Lakatos, P. L.
    Bessissow, T.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I843 - I844
  • [35] HISTOLOGICAL REMISSION USING A NANCY INDEX OF 0 IS ASSOCIATED WITH LONGER RELAPSE-FREE SURVIVAL THAN HISTOLOGICAL ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL AND ENDOSCOPIC REMISSION
    Pudipeddi, Aviv
    Fung, Caroline
    Kariyawasam, Viraj
    Paramsothy, Ramesh
    Ghaly, Simon
    Haifer, Craig
    An, Yoon
    Begun, Jakob
    Connor, Susan
    Chetwood, John
    Paramsothy, Sudarshan
    Leong, Rupert
    GUT, 2022, 71 : A149 - A150
  • [36] Histological remission using a Nancy index of 0 is associated with longer relapse-free survival than histological activity in patients with ulcerative colitis in clinical and endoscopic remission
    Pudipeddi, A.
    Fung, C.
    Kariyawasam, V.
    Paramsothy, R.
    Ghaly, S.
    Haifer, C.
    An, Y.
    Begun, J.
    Connor, S.
    Chetwood, J.
    Paramsothy, S.
    Leong, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 170 - 170
  • [37] Clinical and endoscopic remission with vedolizumab treatment in ulcerative colitis
    Almutairdi, A.
    Ma, C.
    Kotze, P. G.
    Al-Damarki, A.
    Devlin, S.
    Kaplan, G.
    Seow, C.
    Novak, K.
    Lu, C.
    Ferraz, J.
    Stewart, M.
    Buresi, M.
    Mathivanan, M.
    Jijon, H.
    Heatherington, J.
    Martin, M. -L.
    Panaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S430 - S431
  • [38] Mucosal gene transcription of ulcerative colitis in endoscopic remission
    Arkteg, Christian Borde
    Goll, Rasmus
    Gundersen, Mona Dixon
    Anderssen, Endre
    Fenton, Christopher
    Florholmen, Jon
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (02) : 139 - 147
  • [39] Is Endoscopic Remission in Ulcerative Colitis Still Good Enough?
    Bhattacharya, Sumona
    Cross, Raymond K.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (11) : 1729 - 1730
  • [40] Segmental Colectomy: An Alternative for Ulcerative Colitis in Endoscopic Remission?
    Parra, Rogerio Serafim
    Feitosa, Marley Ribeiro
    Feres, Omar
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (02): : 340 - 340